Clinical Trial Update: Therapeutic Drug Monitoring of Guselkumab in Psoriasis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating therapeutic drug monitoring of guselkumab in psoriasis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Psoriasis Vulgaris | Phase 4 | Status: COMPLETED